By Medicines and Healthcare Products Regulatory Agency
Pharmacovigilance is the technology of gathering, tracking, learning, assessing and comparing info from healthcare prone and sufferers at the antagonistic results of medicines, organic items, herbalism and standard drugs on the way to determining new information regarding dangers linked to medications and fighting damage to sufferers. Pharmacovigilance is very excited about adversarial drug reactions.The MHRA has pointed out a necessity for writing and publishing a consultant to "Good Pharmacovigilance Practice". this article enhances present laws and tips, and gives sensible suggestion approximately attaining a suitable method of pharmacovigilance.
Read or Download Good Pharmacovigilance Practice Guide PDF
Similar pharmacy books
Handbook of Pharmaceutical Manufacturing Formulations: Semisolids Products
The fourth quantity within the six-volume instruction manual of Pharmaceutical production Formulations, this publication covers semi-solid medicines. It contains formulations of ointments, creams, gels, and suppositories, from publicly to be had yet generally dispersed details from FDA New Drug purposes (NDA), patent functions, and different resources of common and proprietary formulations.
Independent and Supplementary Prescribing: An Essential Guide
Prescribing and drugs administration is among the most typical interventions in wellbeing and fitness care supply and sooner or later turns into a part of the function of many millions of nurses, pharmacists and different professions allied to medication (PAMs). autonomous and Supplementary Prescribing: a vital consultant is the 1st ebook of its style and explores a few key components for prescribers, together with the moral and felony concerns surrounding prescribing, the psychology and sociology of prescribing, prescribing inside a public overall healthiness context, evidence-based prescribing, prescribing inside of a staff context, simple pharmacology, tracking abilities and drug calculations.
Pharmaceutical Dosage Forms: Tablets, Second Edition, --Volume 3
Whole in three volumes. Pharmaceutical know-how. 14 members.
163 pages, fifty four figures
- Innovation and Marketing in the Pharmaceutical Industry: Emerging Practices, Research, and Policies (International Series in Quantitative Marketing)
- Saunders Nursing Drug Handbook 2016, 1e
- Analytical Methods in Combinatorial Chemistry, Second Edition (Critical Reviews in Combinatorial Chemistry)
- Polyvinylpyrrolidone Excipients for Pharmaceuticals: Povidone, Crospovidone and Copovidone
- Essential Practical Prescribing, 1st Edition
Additional info for Good Pharmacovigilance Practice Guide
The QPPV should assess whether the response provided to one Competent Authority, following a request for information necessary for the evaluation of benefits and risks, should also be provided to other Competent Authorities. This assessment should be documented. Although not a legal requirement, the MAH/QPPV should consider implementing a system to capture and track requests for information from Competent Authorities, and the information provided in response to such requests. The documentation associated with a Competent Authority request and with the MAH’s response to the request should be retained.
5 What Other Tasks Might the Qualified Person for Pharmacovigilance Perform? 1 states that the QPPV should also act as the MAH’s contact point for pharmacovigilance inspections or should be made aware by the MAH of any inspection that may impact the pharmacovigilance system, in order to be available as necessary. MAH procedures should describe the communication process to be followed when an inspection notification is received. The QPPV should be kept informed concerning the inspection arrangements.
Personnel within the pharmacovigilance function must maintain adequate records of all pharmacovigilance data received. 1 Reconciliation When transfer of pharmacovigilance data occurs, the mechanism should be such that there is confidence that all notifications are received, in that a confirmation and/or reconciliation process is undertaken. This is appropriate for both internal transfers, such as that between the medical information and the pharmacovigilance departments, and external transfers, such as that with licence partners.